Aptamers: Promising Reagents in Biomedicine Application
Advanced Biology · 2024-06 · 8 (6)
DOI: 10.1002/adbi.202300584 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biology, online erschienen am 15.03.2024. Verfasst von Hongxin Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, Shanghai, …. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, SELEX Aptamer Technique. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 117 Literaturangaben. Gefördert von: The Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Nucleic acid aptamers, often termed “chemical antibodies,” are short, single‐stranded DNA or RNA molecules, which are selected by SELEX. In addition to their high specificity and affinity comparable to traditional antibodies, aptamers have numerous unique advantages such as wider identification of targets, none or low batch‐to‐batch variations, versatile chemical modifications, rapid mass production, and lack of immunogenicity. These characteristics make aptamers a promising recognition probe for scientific research or even clinical application. Aptamer‐functionalized nanomaterials are now emerged as a promising drug delivery system for various diseases with decreased side‐effects and improved efficacy. In this review, the technological strategies for generating high‐affinity and biostable aptamers are introduced. Moreover, the development of aptamers for their application in biomedicine including aptamer‐based biosensors, aptamer–drug conjugates and aptamer functionalized nanomaterials is comprehensively summarized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Fudan University, Shanghai, 200032, P. R. China.
- Clinical Center for Biotherapy, Zhongshan Hospital, Fudan University, Shanghai, 200032, P. R. China.
ORCID-Profile: Weizhong Wu
Förderung
- The Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Zhou, H., Li, Y., & Wu, W. (2024). Aptamers: Promising Reagents in Biomedicine Application. Advanced Biology, 8(6). https://doi.org/10.1002/adbi.202300584
Vancouver
Zhou H, Li Y, Wu W. Aptamers: Promising Reagents in Biomedicine Application. Advanced Biology. 2024;8(6). doi:10.1002/adbi.202300584
BibTeX
@article{Zhou2024,
author = {Zhou, Hongxin and Li, Yuhuan and Wu, Weizhong},
title = {Aptamers: Promising Reagents in Biomedicine Application},
journal = {Advanced Biology},
year = {2024},
volume = {8},
number = {6},
doi = {10.1002/adbi.202300584}
}
EUVIMED